Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

1,309 results
Display

Genetic Factors in the Screening and Imaging for Breast Cancer

Kim J, Haffty BG

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Digital Breast Tomosynthesis Plus Ultrasound Versus Digital Mammography Plus Ultrasound for Screening Breast Cancer in Women With Dense Breasts

Ha SM, Yi A, Yim D, Jang Mj, Kwon BR, Shin SU, Lee EJ, Lee SH, Moon WK, Chang JM

Objective: To compare the outcomes of digital breast tomosynthesis (DBT) screening combined with ultrasound (US) with those of digital mammography (DM) combined with US in women with dense breasts. Materials and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Incidental Extramammary Findings on Preoperative Breast MRI in Breast Cancer Patients: A Pictorial Essay

Ryoo JA, Kim SY

Breast cancer is one of the most common cancers and causes several complications in females. Currently, MRI is a necessary method for preoperative studies in patients with breast cancer. A high...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The expression of Rab5 and its effect on invasion, migration and exosome secretion in triple negative breast cancer

Qiao L, Dong C, Zhang J, Sun G

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and current therapeutic strategies are limited in their effectiveness. The expressions of Rab5 and the M2 tumor-associated macrophage marker...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Growth inhibition by fusidic acid in cervical, thyroid, and breast carcinoma cell lines

Kim JY, Jegal BS, Koh AR, Park KS, Kim JB, Bae J

ObjectiveWe investigated the effects of fusidic acid (FA) on human cervical, thyroid, and breast carcinoma cell lines to determine the potential usefulness of FA in cancer treatment. MethodsSix cancer cell lines...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Psychosocial Interventions for Patients with Breast Cancer: A Meta-analysis

Hwang KS, Lee KH, Yang CM, Lee HJ, Lee SY

Objective: This study involved a meta-analysis of South Korean studies regarding psychosocial interventions for patients with breast cancer to provide basic data to support the development of an integrated healthcare...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Breast Cancer-Related Lymphedema With Topical Tacrolimus: A Prospective, Open-Label, SingleArm, Phase II Pilot Trial

Hansen FCG, Jørgensen MG, Sørensen JA

Purpose: Breast cancer-related lymphedema (BCRL) is a chronic, progressive side effect of breast cancer treatment, occurring in one-third of patients treated with axillary lymph node dissection and nodal radiotherapy. Cluster...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Breast Cancer to Meningioma: A Rare Case of Tumor-to-Tumor Metastasis

Joe WH, Lee CY, Kim CH, Ko YS, Kim SP, Kwon SM

Tumor-to-tumor metastasis (TTM) is defined as the hematogenous metastasis within a primary host tumor from a donor neoplasm. Since there is insufficient evidence regarding the pathophysiology, clinical course, and management...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Breast Imaging Reporting and Data System (BI-RADS): Advantages and Limitations

Choi JS

Breast Imaging Reporting and Data System (BI-RADS) is a communication and data tracking system that standardizes and controls the quality of reporting by presenting lexicon descriptors, assessment categories, and recommendations...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Significance and Characteristics of Newly Detected Lesions on Breast MRI During Neoadjuvant Chemotherapy

Lee K, Nam KJ, Choo KS, Nam SB, Kim HY, Jung YJ, Kim JJ, Joo JH, Kim JY, Lee JW, Hwang JY, Park C

Purpose This study aimed to evaluate clinical significance and imaging findings of newly detected lesions on breast MRI while monitoring patients’ response to neoadjuvant chemotherapy (NAC). Materials and Methods We identified 291 patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates

Kim N, Kim YB

Historical conventional fractionated radiation therapy (RT) for breast cancer consisted of 1.8–2.0 Gy per fraction with a total dose of 45–60 Gy over 5–7 weeks. Based on radiobiological characteristics, a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Use of Artificial Intelligence for Reducing Unnecessary Recalls at Screening Mammography: A Simulation Study

Kim YS, Jang Mj, Lee SH, Kim SY, Ha SM, Kwon BR, Moon WK, Chang JM

Objective: To conduct a simulation study to determine whether artificial intelligence (AI)-aided mammography reading can reduce unnecessary recalls while maintaining cancer detection ability in women recalled after mammography screening. Materials and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of equipotent doses of propofol and sevoflurane on endoplasmic reticulum stress during breast cancer surgery

Oh CS, Hong SW, Park S, Kwon Y, Kim SH

Background: Numerous studies suggest that intravenous propofol is superior to inhaled volatile anesthetic. This study compared the changes in the endoplasmic reticulum (ER) stress of cancer cells and lymphocytes after...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk of Breast Cancer in Association with the Use of Second-generation Antipsychotics

Joo SW, Lee BC, Lee J, Seo GH

Objective: Previous studies regarding the relationship between the risk of breast cancer (BC) and antipsychotics use have reported inconsistent findings. Insufficient sample size and/or observation period may have hindered revealing...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Temperament on the Association Between Pre-treatment Anxiety and Chemotherapy-Related Symptoms in Patients With Breast Cancer

Choi JI, Jung S, Oh GH, Son KL, Lee KM, Jung D, Kim TY, Im SA, Lee KH, Shin MS, Hahm BJ, Yeom CW

Objective Pre-treatment anxiety (PA) before chemotherapy increases complaints of chemotherapy-related symptoms (CRS). The results on the association have been inconsistent, and the effect of temperament remains unclear. We aimed to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hydroxyzine Induces Cell Death in Triple-Negative Breast Cancer Cells via Mitochondrial Superoxide and Modulation of Jak2/STAT3 Signaling

Shakya R, Park GH, Joo SH, Shim JH, Choi JS

Treatment of triple-negative breast cancer (TNBC) has been limited due to the lack of molecular targets. In this study, we evaluated the cytotoxicity of hydroxyzine, a histamine H1 receptor antagonist...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Digital Breast Tomosynthesis versus MRI as an Adjunct to Full-Field Digital Mammography for Preoperative Evaluation of Breast Cancer according to Mammographic Density

Kim H, Yang SY, Ahn JH, Ko EY, Ko ES, Han BK, Choi JS

Objective: To compare digital breast tomosynthesis (DBT) and MRI as an adjunct to full-field digital mammography (FFDM) for the preoperative evaluation of women with breast cancer based on mammographic density. Materials...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Imaging Findings of Metaplastic Breast Carcinoma with Chondroid Differentiation: A Case Reports

Kim JY, Kim SH, Jeong MJ, Lee JH, Kang MJ, Gwak G, Yoo SH

Metaplastic carcinoma of the breast is a heterogeneous group of neoplasms with mixed epithelial and mesenchymal differentiation. Metaplastic carcinoma of the breast is a rare and aggressive malignancy, with high...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Real-World Evidence of Trastuzumab, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic Breast Cancer

Lee YP, Lee MS, Kim H, Kim JY, Ahn JS, Im YH, Park YH

Purpose Trastuzumab has markedly improved the survival outcomes of patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer, and dual blockade of HER2 using trastuzumab and pertuzumab in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience

Kim JY, Nam SJ, Lee JE, Yu J, Chae BJ, Lee SK, Ryu JM, Ahn JS, Im YH, Kim SW, Park YH

Purpose Docetaxel/carboplatin/trastuzumab/pertuzumab (TCHP) regimen is frequently used to treat early and locally advanced human epidermal growth factor receptor 2 (HER2)–positive breast cancer (BC) in neoadjuvant setting. However, large-scaled real-world evidence...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr